Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9862627 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer
Condition: Kidney Neoplasms
Interventions: Drug: IL-2 (interleukin-2);   Drug: OKT3;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Mesna

Indicates status has not been verified in more than two years